R&D channel feed – Endpoints News

R&D channel feed

Step 3: Sanofi commits up to $100M to opt-in on Alnylam’s PhIII RNAi hemophilia trial

9 years ago

Dynavax shares crater after the FDA rejects Heplisav-B, again, and CEO signals for help

9 years ago

Under a short assault, Corbus counterattacks with positive PhII data for systemic sclerosis drug

9 years ago

J&J, GSK stumble coming out of the gate with mixed PhIII rheumatoid arthritis data for sirukumab

9 years ago

Polaris cashes in its chips as Langer-backed Arsia is auctioned off to Eagle for up to $78M

9 years ago

Ultragenyx nixes plan to seek quick OK for rare disease drug in Europe

9 years ago

PTC shares rocket up as European regulators offer a thumbs-up on Duchenne drug marketing

9 years ago

Kleiner Perkins-backed Elcelyx says its reformulated metformin worked in a PhIIb diabetes study

9 years ago

Bristol-Myers scores fresh bragging rights with PhIII gastric cancer success for Opdivo

9 years ago

Cell Medica signs up for an off-the-shelf CAR-T collaboration with Baylor

9 years ago

AstraZeneca axes another R&D track on durvalumab after once again falling behind rivals

9 years ago

Crushed by a PhIII flop, Novavax slashes jobs as it looks to chop out up to $100M in costs

9 years ago

Celgene EVP Rich Bagger makes Politico’s short list for Trump’s Cabinet

9 years ago

Kite gives itself a little more time to finish FDA application for KTE-C19

9 years ago

As election storm gathered, Arrowhead drops word about a clinical hold

9 years ago

CureVac grabs a $29.5M round to fuel its mRNA development efforts

9 years ago

Versant’s global biotech team is reloading with $350M-plus fund

9 years ago

Cardio event forces FDA to halt a Penn PhII study for multiple myeloma

9 years ago

Cardio drug at The Medicines Co gets the heave-ho. (But they prefer PCSK9 anyway.)

9 years ago

Roche flags early success for Tecentriq combos, hustles into PhIIIs

9 years ago

Poised to launch a new drug for SMA, Biogen and Ionis shares jump on more promising PhIII data

9 years ago

Sanofi jumps into a pivotal study for next-gen Pompe drug

9 years ago

Nestlé invests $145M in Aimmune’s food allergy R&D work, taking the head seat at the deal table

9 years ago

Celyad chief blasts Cellectis’ CEO Choulika, claiming he lied about CAR-T patent

9 years ago

First page Previous page 312 313 314315316 317 318 Next page Last page